Understanding and preventing bacterial vaginosis recurrence

Integrating multi-omics data: Modeling biomarkers and mechanisms to reduce bacterial vaginosis recurrence

NIH-funded research University of Maryland Baltimore · NIH-11097211

This study is looking at bacterial vaginosis (BV) to find out how we can better predict and prevent it from coming back, helping women manage this common condition more effectively.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-11097211 on NIH RePORTER

What this research studies

This research investigates bacterial vaginosis (BV), a common condition affecting many women, particularly in North America and sub-Saharan Africa. It aims to analyze the vaginal microbiome and related factors to develop a way to predict and prevent BV recurrence. By integrating data from microbiomes and immune markers, the study seeks to identify biomarkers that could help in managing BV more effectively. This approach could lead to better treatment options and improved health outcomes for women suffering from this condition.

Who could benefit from this research

Good fit: Ideal candidates for this research are reproductive-age women who have experienced bacterial vaginosis, particularly those with recurrent cases.

Not a fit: Patients who have never experienced bacterial vaginosis or those with other unrelated vaginal conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments that significantly reduce the recurrence of bacterial vaginosis.

How similar studies have performed: Previous research has shown promise in understanding the vaginal microbiome's role in BV, indicating that this approach could yield valuable insights.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.